NATCO PHARMA
Back to Cashflow Statement
|
NATCO PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-211 Cr | ₹-247 Cr | ₹-363 Cr | ₹35 Cr | ₹-186 Cr |
What is the latest Cash Flow from Financing Activities ratio of NATCO PHARMA ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2025 | ₹-211 Cr |
Mar2024 | ₹-247 Cr |
Mar2023 | ₹-363 Cr |
Mar2022 | ₹35 Cr |
Mar2021 | ₹-186 Cr |
How is Cash Flow from Financing Activities of NATCO PHARMA Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹-211 Cr | Negative | |
Mar2024 | ₹-247 Cr | Negative | |
Mar2023 | ₹-363 Cr | Negative | |
Mar2022 | ₹35 Cr | Positive | |
Mar2021 | ₹-186 Cr | - |
Compare Cash Flow from Financing Activities of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹14,797.2 Cr | -1.7% | -3.7% | -40.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,872.0 Cr | 0.6% | 3.6% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,706.0 Cr | 1% | 9.4% | 8% | Stock Analytics | |
CIPLA | ₹127,449.0 Cr | 0.9% | 1.2% | -0.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,125.0 Cr | 1.7% | 1% | 1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,827.0 Cr | -0.5% | -4.2% | -6.3% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | -1.7% |
-3.7% |
-40.9% |
SENSEX | 1.8% |
1.9% |
2.4% |
You may also like the below Video Courses